November 24, 2009
LONDON (AP) - The pharmaceutical company GlaxoSmithKline says it has advised medical staff in Canada to not use one batch of swine
flu vaccine for fear it may trigger life-threatening allergies.
GlaxoSmithKline spokeswoman Gwenan White said Tuesday the
company issued the advice after reports that one batch of the swine
flu vaccine might have caused more allergic reactions than normal.
She says the affected batch contains 172,000 doses of the
vaccine. She declined to say how many doses had been administered
before the advice to stop using them was given.
White says GlaxoSmithKline wrote to Canadian healthcare
professionals advising them to stop using the batch on Nov. 18. She
says a total of 7.5 million doses of the vaccine have been
distributed in Canada.
Viewers with disabilities can get assistance accessing this station's FCC Public Inspection File by contacting the station with the information listed below. Questions or concerns relating to the accessibility of the FCC's online public file system should be directed to the FCC at 888-225-5322, 888-835-5322 (TTY), or email@example.com.